Cargando...
Phase II trial of paclitaxel, 13-cis retinoic acid and interferon alfa-2b in the treatment of advanced stage or recurrent cervical cancer
OBJECTIVE: Overexpression of bcl-2 is a mechanism of drug resistance in cervical cancer. Agents that downregulate bcl-2 may decrease tumor cell threshold and sensitize tumor cells to chemotherapy. The objective of this multi-institutional phase II trial was to evaluate the efficacy and toxicity of p...
Gardado en:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4211961/ https://ncbi.nlm.nih.gov/pubmed/25304678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IGC.0000000000000258 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|